Leaflet MILRICOR 10mg / 10ml I.V. solution for injection / infusion
Milrinone is a phosphodiesterase type 3 inhibitor used for the treatment of acute decompensated heart failure. It works by increasing myocardial contractility and causing vasodilation, thereby improving cardiac function.
The medication is administered via intravenous infusion, with the dose adjusted based on the patient's weight and hemodynamic response. Common side effects include hypotension, arrhythmias, and headaches.
Milrinone is contraindicated in patients with hypersensitivity to the active substance or severe obstructive valvular conditions. Its use also requires careful monitoring of cardiac function and blood pressure.
This medication is an important option for patients with severe heart failure, helping to stabilize hemodynamic status and alleviate symptoms.
The medication is administered via intravenous infusion, with the dose adjusted based on the patient's weight and hemodynamic response. Common side effects include hypotension, arrhythmias, and headaches.
Milrinone is contraindicated in patients with hypersensitivity to the active substance or severe obstructive valvular conditions. Its use also requires careful monitoring of cardiac function and blood pressure.
This medication is an important option for patients with severe heart failure, helping to stabilize hemodynamic status and alleviate symptoms.
General data about MILRICOR 10mg / 10ml I.V.
- Substance:
- milrinone
- Date of latest medicines list:
- 01-03-2025
- Product code:
- W70006001
- Concentration:
- 10mg / 10ml
- Pharmaceutical form:
- solution for injection / infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for milrinone
Concentrations available for milrinone
- 10mg
- 10mg/10ml
- 1mg/ml